Skip to main content
. 2012 Sep 28;2:54. doi: 10.1186/2191-219X-2-54

Figure 4.

Figure 4

Comparison of tumor/tissue uptake ratio (mean ± SD) of (+)-[125I]IV-OH. At 1-h post-injection under no-carrier-added condition and under co-injection of haloperidol, SA4503, or (+)-pIV. Significance was determined using one-way ANOVA followed by Dunnett's post hoc test (p < 0.01 vs. control (asterisk)).